Effectiveness of practices for improving the diagnostic accuracy of Non ST Elevation Myocardial Infarction in the Emergency Department: A Laboratory Medicine Best Practices™ systematic review

Clinical Biochemistry

Volumn 48, Issue 4-5, 2015, Pages 204-212

  Layfield, Christopher ^a   Rose, John ^a   Alford, Aaron ^a   Snyder, Susan R ^b   Apple, Fred S ^c,d   Chowdhury, Farah M ^e   Kontos, Michael C ^f   Newby, L Kristin ^g   Storrow, Alan B ^h   Tanasijevic, Milenko ^i,j   Leibach, Elizabeth ^e   Liebow, Edward B ^k   Christenson, Robert H ^l  

^a BATTELLE MEMORIAL INSTITUTE   (United States)

^b Geisinger Center for Health Research   (United States)

^c HENNEPIN COUNTY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j HARVARD MEDICAL SCHOOL   (United States)

^k American Anthropological Association   (United States)

^l UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Acute coronary syndrome; Cardiac troponin; Myocardial infarction; Non ST segment elevation

Indexed keywords

BIOLOGICAL MARKER; TROPONIN; TROPONIN I; TROPONIN T;

COST CONTROL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HEALTH CARE COST; HUMAN; LENGTH OF STAY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; POINT OF CARE TESTING; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TOTAL QUALITY MANAGEMENT; TURNAROUND TIME; BLOOD; EMERGENCY HEALTH SERVICE; MYOCARDIAL INFARCTION; PRACTICE GUIDELINE; STANDARDS;

BIOMARKERS; EMERGENCY SERVICE, HOSPITAL; HUMANS; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; TROPONIN; TROPONIN I; TROPONIN T;

EID: 84924574551     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2015.01.014     Document Type: Review

References (64)

1. Thygesen K., Alpert J.S., Jaffe A.S., Simons M.L., Chaitman B.R., White H.D., et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012, 60:1581-1598.
2. Sandoval Y., Smith S.W., Apple F.S. Supply/demand type 2 myocardial infarction: should we be paying more attention?. J Am Coll Cardiol 2014, 63:2079-2087.
3. Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin E.J., Berry J.D., Borden W.B., et al. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation 2012, 125(1):e2-e220.
4. Amsterdam E.A., Wenger N.K., Brindis R.G., Casey D.E., Ganiats T.G., Holmes D.R., et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2014, 10.1016/j.jacc.2014.09.017.
5. Morrow D.A., Cannon C.P., Jesse R.L., Newby L.K., Ravkilde J., Storrow A.B., et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 2007, 115:e356-e375.
6. Christenson R.H., Snyder S.R., Shaw C.S., Derzon J.H., Black R.S., Mass D., et al. Laboratory medicine best practices: systematic evidence review and evaluation methods for quality improvement. Clin Chem 2011, 57(6):816-825.
7. Alpert J.S., Thygesen K., Antman E., Bassand J.P. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000, 36(3):959-969.
8. Apple F.S., Collinson P.O., IFCC Task Force on Clinical Applications of Cardiac Biomarkers Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012, 57(1):54-61.
9. Reichlin T., Hochholzer W., Bassetti S., Steuer S., Stelzig C., Hartwiger S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009, 361:858-867.
10. Anderson J.L., Adams C.D., Antman E.M., Bridges C.R., Calif R.M., Casey D.E., et al. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013, 61(23):e179-e347.
11. Panteghini M., Pagani F., Yeo K.T., Apple F.S., Christenson R.H., Dati F., et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004, 5D(2):327-332.
12. Bonham M., Miller S. Clinical comparison of 99th percentile and 10% coefficient of variation cutoff values for four commercially available troponin I assays. LabMedicine 2009, 40(8):470-473. 10.1309/LMFBC68TIZGVHOHV.
13. Kavsak P.A., MacRae A.R., Palomaki G.F., Newman A.M., Ko D.T., Lustig V., et al. Health outcomes categorized by current and previous definitions of acute myocardial infarction in an unselected cohort of troponin-naive emergency department patients. Clin Chem 2006, 52(11):2028-2035.
14. Apple F.S., Parvin C.A., Buechler K.F., Christenson R.H., Wi A.H.B., Jaffe A.S. Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. Clin Chem 2005, 51(11):2198-2200.
15. Kupchak P., Wu A.W.B., Ghani F., Newby K.L., Ohman E.M., Christenson R.H. Influence of imprecision on ROC curve analysis for cardiac markers. Clin Chem 2006, 52(4):752-753.
16. Kavsak P.A., MacRae A.R., Lustig V., Bhargava R., Vandersluis R., Palomaki G.E., et al. The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction. Am Heart J 2006, 152(1):118-125.
17. Collinson P.O., van Dieijen-Visser M.P., Pulkki K., Hammerer-Lercher A., Suvisaari J., Ravkilde J., et al. Evidence-based laboratory medicine: how well do laboratories follow recommendations and guidelines? The cardiac marker guideline uptake in Europe (CARMAGUE) study. Clin Chem 2012, 58(1):305-306.
18. Newby L.K., Christenson R.H., Ohman E.M., Armstrong P.W., Thompson T.D., Lee K.L., et al. Value of serial troponin T Measures for early and late risk stratification in patients with acute coronary syndromes. Circulation 1998, 98:1853-1859.
19. Loughrey B.V., Spedding R.L., Herity N.A., Murphy J.C., Walker E., Graham W.R., et al. Prospective survey of serial troponin T requesting in an acute teaching hospital. Ulster Med J 2007, 76(3):150-153.
20. MacRae A.R., Kavask P.A., Lustig V., Bharqava R., Vandersluis R., Palomaki G.E., et al. Assessing the requirement for the 6-hour interval between specimens in the American Heart Association classification of myocardial infarction in epidemiology and clinical research studies. Clin Chem 2006, 52(5):812-818.
21. Archar S.A., Kundu S., Norcross W.A. Diagnosis of acute coronary syndrome. Am Fam Physician 2005, 72(1):119-126. [http://www.aafp.org/afp/2005/0701/p119.html Accessed 8/24/2012].
22. Institute for Clinical Systems Improvement (ICSI) Diagnosis and treatment of chest pain and acute coronary syndrome (ACS) [Accessed 8/24/2012]. http://www.ICSI.org.
23. Kumar A., Cannon C.P. Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc 2009, 84(10):917-938.
24. Kavsak P.A., Allen L.C., Apple F.S., Booth R.A., Chan P.C., Delvin E., et al. Cardiac troponin testing in the acute care setting: ordering, reporting, and high sensitivity assays - an update from the Canadian Society of Clinical Chemists (CSCC). Clin Biochem 2011, 44(16):1273-1277.
25. Haaf P., Drexler B., Reichlin T., Twerenbld R., Reiter M., Meissner J., et al. High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease. Circulation 2012, 126(1):31-40.
26. Keller T., Zeller T., Ojeda F., Tzikas S, Lillpopp L., et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011, 306(24):2684-2693.
27. Than M., Cullen L., Reid C.M., Lim S.H., Aldous S., Ardagh M.W., et al. A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet 2011, 377(9771):1077-1084.
28. Than M., Cullen L., Aldous S., Parsonage W.A., Reid C.M., Greenslade J., et al. 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. JACC 2012, 59:2091-2098.
29. Reichlin T., Irfan A., Twerenbold R., Reiter M., Hockholzer W., Burkhalter H., et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011, 124:136-145. 10.1161/CIRCULATIONHA.111.023937.
30. Nichols J.H., Christenson R.H., Clarke W., Gronowski A., Hammett-Stabler C.A., Jacobs E., et al. Executive summary. the National Academy of Clinical Biochemistry Laboratory Medicine Practice Guideline: evidence-based practice for point-of-care testing. Clin Chim Acta 2007, 379:14-28.
31. Ryan R.J., Lindsell C.J., Hollander J.E., O'Neill B., Jackson R., Schreiber D., et al. A multicenter randomized controlled trial comparing central laboratory and point-of-care cardiac marker testing strategies: the disposition impacted by serial point of care markers in acute coronary syndromes (DISPO-ACS) trial. Ann Emerg Med 2009, 53(3):321-328.
32. Singer A.J., Ardise J., Gulla J., Cangro J. Point-of-care testing reduces length of stay in emergency department chest pain patients. Ann Emerg Med 2005, 45(6):587-591.
33. Storrow A.B., Lyon J.A., Porter M.W., Zhou C., Han J.H., Lindsell C.J. A systematic review of emergency department point-of-care cardiac markers and efficiency measures. Point Care 2009, 8:121-125.
34. Apple F.S., Chung A.Y., Kogut M.E., Bubany S., Murakami M.M. Decreased patient charges following implementation of point-of-care cardiac troponin monitoring in acute coronary syndrome patients in a community hospital cardiology unit. Clin Chim Acta 2006, 370(1-2):191-195.
35. Goodacre S.W., Bradburn M., Cross E., Collinson P., Gray A., Hall A.S. The randomised assessment of treatment using panel assay of cardiac markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Heart 2010, 97(3):190-196.
36. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gøtzsche P.C., Ioannidis J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009, 6(7):e1000100. 10.1371/journal.pmed.1000100.
37. Apple F.S. Point-of-care cardiac troponin testing: process improvements for detection of acute myocardial infarction. Point Care 2006, 5(1):25-27.
38. Collinson P., Goodacre S., Gaze D., Gray A. Very early diagnosis of chest pain by point-of-care testing: comparison of the diagnostic efficiency of a panel of cardiac biomarkers compared with troponin measurement along in the RATPAC trial. Heart 2011, 10.1136/heartjnl-2011-300723.
39. Eggers K.M., Oldgren J., Nordenskjold A., Lindahl B. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am Heart J 2004, 148(4):574-581.
40. Keller T., Zeller T., Peetz D., Tzikas S., Roth A., et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. NEJM 2009, 361:868-877.
41. Mozina H., Vukan V., Lenart K., Skitek M., Osredkar J. Quantitative point-of-care troponin I in emergency department in comparison with troponin I in central laboratory. Point Care 2010, 9(1):8-11.
42. Storrow A., Nowak R., Diercks D.B., Singer A.J., Wu A.H.B., et al. Absolute and relative changes (delta) in troponin I for early diagnosis of myocardial infarction: results of a prospective multicenter trial. Clin Biochem 2015, 48(4-5):263-271.
43. Straface A.L., Myers J.H., Kirchick H.J., Blick K.E. A rapid point-of-care cardiac marker testing strategy facilitates the rapid diagnosis and management of chest pain patients in the emergency department. Am J Clin Pathol 2008, 129(5):788-795.
44. Chang S.S., Lee S.H., Wu J.Y., Ning H.C., Chiu T.F., Wang F.L., et al. Evaluation of the value of rapid D-dimer test in conjunction with cardiac troponin I test for early risk stratification of myocardial infarction. J Thromb Thrombolysis 2010, 40(4):427-428.
45. Engel G., Rockson S.G. Rapid diagnosis of myocardial injury with troponin T and CK-MB relative index. Mol Diagn Ther 2007, 11(2):109-116.
46. Jernberg T., Lindahl B., James S., Ronquist G., Wallentin L. Comparison between strategies using creatine kinase-MB (mass), myoglobin, and troponin T in the early detection or exclusion of acute myocardial infarction in patients with chest pain and a nondiagnostic electrocardiogram. Am J Cardiol 2000, 86(12):1367-1371.
47. McCord J., Nowak R.M., McCullough P.A., Foreback C., Borzack S., Tokarski G., et al. Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin. Circulation 2001, 104:1483-1488.
48. Hsu L.F., Koh T.H., Lim Y.L. Cardiac marker point-of-care testing: evaluation of rapid on-site biochemical marker analysis for diagnosis of acute myocardial infarction 2000, 29:421-427.
49. mass 2001, 21:382-389.
50. Meune C., Zuily S., Wahbi K., Claessens Y., Weber S., Cheneview-Gobeaux C. Combination of copeptin and high-sensitivity cardiac troponin T assay in unstable angina and non-ST-segment elevation myocardial infarction: a pilot study. Arch Cardiovasc Dis 2011, 104:4-10. 10.1016/j.acvd.2010.11.002.
51. Mills N., Churchhouse A., Lee K., Anand A., Gamble D., et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 2011, 305(12):1210-1216.
52. Kontos M.C., Shah R., Fritz L.M., Anderson F.L., Tatum J.L., Ornato J.P., et al. Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients. J Am Coll Cardiol 2004, 42(6):958-965.
53. Morrow D.A., Cannon C.P., Rifai N., Frey M.K., Vicari R., Lakkis N., et al. Ability of minor elevations of troponin I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 2001, 286(19):2405-2412.
54. Body R., Carley S., McDowell, Jaffe A.S., France M., et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. JACC 2011, 58(13):1332-1339.
55. Heeschen C., Goldmann B.U., Langenbrink L., Matschuck G., Hamm C.W. Evaluation of a rapid whole blood ELISA for quantification of troponin I in patients with acute chest pain. Clin Chem 1999, 45:1789-1796.
56. Kelly A.M. Performance of a sensitive troponin assay in the early diagnosis of acute myocardial infarction in the emergency department. Emerg Med Australas 2011, 23(2):181-185.
57. Di Serio F., Caputo M., Zaninotto M., Ottomano C., Plebani M. Evaluation of analytical performance of the pathfast cardiac troponin I. Clin Chem Lab Med 2009, 47(7):829-833.
58. Hallani H., Leung D.Y., Newland E., Jeurgens C.P. Use of quantitative point-of-care test for the detection of serum cardiac troponin T in patients with suspected acute coronary syndromes. Intern Med J 2005, 35:560-562.
59. Caragher T., Fernandez B.B., Jacobs F., Barr L.A. Evaluation of quantitative cardiac biomarker point-of-case testing in the emergency department. J Emerg Med 2002, 22(1):1-7.
60. Lotten C., Attia J., Hullick C., Marley J., McElduff P. Point of care troponin decreases time in the emergency department for patients with possible acute coronary syndrome: a randomized controlled trial. Emerg Med J 2010, 27:194-198.
61. Bock J.L., Singer A.J., Thode H.C. Comparison of emergency department patient classification by point-of-care and central laboratory methods for cardiac troponin I. Clin Chem 2008, 130(1):132-135.
62. Lee-Lewandrowski E., Januzzi J.L., Grisson R., Mohammed A.A., Lewandrowski G., Lewandrowski K. Evaluation of first-draw whole blood, point-of-care cardiac markers in the context of the universal definition of myocardial infarction: a comparison of a multimarker panel to troponin alone and to testing in the central laboratory. Arch Pathol Lab Med 2011, 135(4):459-463.
63. Vaidya A., Severens J.L., Bongaerts B.W., Cleutiens K.B., Nelemans P.J., Hofstra L., et al. High-sensitive troponin T assay for the diagnosis of acute myocardial infarction: an economic evaluation. BMC Cardiovasc Disord 2014, 14-77. 10.1186/1471-2261-14-77.
64. Goodacre S., Thokala P., Carroll C., Stevens J.W., Leaviss J., Al Khalaf M., et al. Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome. Health Technol Assess 2013, 17(1):v-vi. [1-188].